Citations

Showing 10 of 108094 citations.

Harvey Cushing’s management of neurogenic thoracic outlet syndrome
Pendleton, Courtney , Belzberg, Allan J. , Spinner, Robert J. , Quiñones‐Hinojosa, Alfredo

Mayo Clinic

Journal of Neurosurgery | April 13, 2018 | Volume: 130 | Issue: 3 | Pages: 712-715

10.3171/2017.9.jns17173 | PMID 29652235 Get It

Harvey Cushing is widely regarded as one of the forefathers of neurosurgery, and is primarily associated with his work on intracranial pathology. However, he had a clinical and academic interest in peripheral nerve surgery. Through the courtesy of the Alan Mason Chesney Medical Archives, the surgical records of the Johns Hopkins Hospital from 1896 to 1912 were reviewed. The records of a single patient undergoing brachial plexus exploration and cervical rib resection were selected for detailed review. The operative report and accompanying illustrations demonstrate Cushing’s interest in adding approaches to the pathology of the brachial plexus to his operative armamentarium.
Intravital microscopy in the study of the tumor microenvironment: from bench to human application
Fisher, Daniel T., Evans, Sharon S. , Skitzki, Joseph J. , Gabriel, Emmanuel M, Gabriel, Emmanuel , Takabe, Kazuaki

Mayo Clinic

Oncotarget | April 13, 2018 | Volume: 9 | Issue: 28 | Pages: 20165-20178

10.18632/oncotarget.24957 | PMID 29732011 Get It

Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure
Reichold, Markus, Klootwijk, Enriko, Reinders, Jörg , Milani, Mario , Broeker, Carsten, Laing, Chris, Wiesner, J., Devi, Sulochana, Zhou, Weibin , Schmitt, Roland , Tegtmeier, Ines , Sterner, Christina, Doellerer, Hannes, Renner, Kathrin , Oefner, Peter J. , Dettmer, Katja , Simbuerger, Johann M.B., Stanescu, Horia , Dumitriu, Simona, Patel, Vaksha , Mozere, Monika, Tekman, Mehmet , Jaureguiberry, Graciana, Issler, Naomi, Kesselheim, Anne, Walsh, Stephen B. , Gale, Daniel P. , Howie, Alexander J. , Martins, Joana Raquel , Hall, Andrew M. , Kasgharian, Michael, O’Brien, Kevin , Jain, Mahim , Hammers, Alexander , Charles‐Edwards, Geoff , Choe, Chi‐un , Isbrandt, Dirk , Cebrian-Serrano, Alberto , Sandford, Richard , Konecki, David, Povey, Sue, Lichter‐Konecki, Uta , Gahl, William A. , Warth, Richard , Kleta, Robert , Gale, Daniel P , Davies, Ben , Bockenhauer, Detlef , Warth, Richard , Kleta, Robert , Otto, Edgar A. , Witzgall, Ralph , Iancu, Daniela , Ferreira, Carlos R , Atwal, Paldeep S , Pugh, Christopher William , Unwin, Robert John

Mayo Clinic

Journal of the American Society of Nephrology | April 13, 2018 | Volume: 29 | Issue: 7 | Pages: 1849-1858

10.1681/asn.2017111179 | PMID 29654216 Get It

Background For many patients with kidney failure, the cause and underlying defect remain unknown. Here, we describe a novel mechanism of a genetic order characterized by renal Fanconi syndrome and kidney failure. Methods We clinically and genetically characterized members of five families with autosomal dominant renal Fanconi syndrome and kidney failure. We performed genome-wide linkage analysis, sequencing, and expression studies in kidney biopsy specimens and renal cells along with knockout mouse studies and evaluations of mitochondrial morphology and function. Structural studies examined the effects of recognized mutations. Results The renal disease in these patients resulted from monoallelic mutations in the gene encoding glycine amidinotransferase (GATM), a renal proximal tubular enzyme in the creatine biosynthetic pathway that is otherwise associated with a recessive disorder of creatine deficiency. In silico analysis showed that the particular GATM mutations, identified in 28 members of the five families, create an additional interaction interface within the GATM protein and likely cause the linear aggregation of GATM observed in patient biopsy specimens and cultured proximal tubule cells. GATM aggregates-containing mitochondria were elongated and associated with increased ROS production, activation of the NLRP3 inflammasome, enhanced expression of the profibrotic cytokine IL-18, and increased cell death. Conclusions In this novel genetic disorder, fully penetrant heterozygous missense mutations in GATM trigger intramitochondrial fibrillary deposition of GATM and lead to elongated and abnormal mitochondria. We speculate that this renal proximal tubular mitochondrial pathology initiates a response from the inflammasome, with subsequent development of kidney fibrosis.
Long-term tumor control following stereotactic radiosurgery for jugular paraganglioma using 3D volumetric segmentation
Patel, Neil , Carlson, Matthew L. , Pollock, Bruce E. , Driscoll, Colin L. W., Neff, Brian A., Foote, Robert L. , Lohse, Christine M. , Link, Michael J.

Mayo Clinic

Journal of Neurosurgery | April 13, 2018 | Volume: No volume available | Issue: No issue available | Pages: 1-9

10.3171/2017.10.jns17764 | PMID 29652232 Get It

OBJECTIVE The morbidity of gross-total resection of jugular paraganglioma (JP) is often unacceptable due to the potential for irreversible lower cranial neuropathy. Stereotactic radiosurgery (SRS) has been used at the authors’ institution since 1990 for the treatment of JP and other benign intracranial tumors. Conventional means of assessing tumor progression using linear measurements or elliptical approximations are imprecise due to the irregular shape and insinuating growth pattern of JP. The objective of this study was to assess long-term tumor control in these patients by using slice-by-slice 3D volumetric segmentation of serial MRI data. METHODS Radiographic data and clinical records were reviewed retrospectively at a single, tertiary-care academic referral center for patients treated from 1990 to 2017. Volumetric analyses by integration of consecutive tumor cross-sectional areas (tumor segmentation) of serial MRI data were performed. Tumor progression was defined as volumetric growth of 15% or greater over the imaging interval. Primary outcomes analyzed included survival free of radiographic and clinical progression. Secondary outcomes included new or worsened cranial neuropathy. RESULTS A total of 85 patients were treated with Gamma Knife radiosurgery (GKRS) for JP at the authors’ institution over the last 27 years. Sixty patients had pretreatment and serial posttreatment contrast-enhanced MRI follow-up suitable for volumetric analysis. A total of 214 MR images were analyzed to segment tumor images in a slice-by-slice fashion to calculate integral tumor volume. The median follow-up duration was 66 months (range 7–202 months). At 5 years the tumor progression-free survival rate was 98%. Three tumors exhibited progression more than 10 years after GKRS. Estimated survival free of radiographic progression rates (95% confidence interval [CI]; n = number still at risk) at 5, 10, and 15 years following radiosurgery were 98% (95% CI 94%–100%; n = 34), 94% (95% CI 85%–100%; n = 16), and 74% (95% CI 56%–98%; n = 6), respectively. One patient with tumor progression required treatment intervention using external beam radiation therapy, constituting the only case of clinical progression. Two patients (3%) without preexisting lower cranial nerve dysfunction developed new ipsilateral vocal fold paralysis following radiosurgery. CONCLUSIONS SRS achieves excellent long-term tumor control for JP without a high risk for new or worsened cranial neuropathy when used in primary, combined modality, or recurrent settings. Long-term follow-up is critical due to the potential for late radiographic progression (i.e., more than 10 years after SRS). As none of the patients with late progression have required salvage therapy, the clinical implications of this degree of tumor growth have yet to be determined.
Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST‐Segment–Elevation Myocardial Infarction: A Systematic Review and Meta‐Analysis
Villablanca, Pedro , Olmedo, Wilman, Weinreich, Michael , Kassas, Ibrahim, Briceño, David , Sanina, Cristina , Brevik, Thomas, Ong, Emily , Attubato, Michael , Menegus, Mark, Wiley, José , Ramakrishna, Harish , Gupta, Tanush , Mohananey, Divyanshu , Albuquerque, Felipe N. , Kalra, Ankur

Mayo Clinic

Journal of the American Heart Association | April 13, 2018 | Volume: 7 | Issue: 8 | Pages: No page available

10.1161/jaha.117.008415 | PMID 29654206 Get It

Background Studies have shown that chronic total occlusion ( CTO ) in a noninfarct‐related artery in patients with ST‐segment–elevation myocardial infarction is linked to increased mortality. It remains unclear whether staged revascularization of a noninfarct‐related artery CTO in patients with ST‐segment–elevation myocardial infarction translates to improved outcomes. We performed a meta‐analysis to compare outcomes between patients presenting with ST‐segment–elevation myocardial infarction with concurrent CTO who underwent percutaneous coronary intervention of noninfarct‐related artery CTO versus those who did not. Method and Results We conducted an electronic database search of all published data. The primary end point was major adverse cardiovascular events. Secondary end points were all‐cause mortality, cardiovascular mortality, myocardial infarction, repeat revascularization with either percutaneous coronary intervention or coronary artery bypass grafting, stroke, and heart failure readmission. Odds ratios ( ORs ) and 95% confidence intervals ( CIs ) were computed. Random effects model was used and heterogeneity was considered if I 2 >25. Six studies (n=1253 patients) were included in the analysis. There was a significant difference in major adverse cardiovascular events ( OR , 0.54; 95% CI , 0.32–0.91), cardiovascular mortality ( OR , 0.43; 95% CI , 0.20–0.95), and heart failure readmissions ( OR , 0.57; 95% CI , 0.36–0.89), favoring the patients in the CTO percutaneous coronary intervention group. No significant differences were observed between the 2 groups for all‐cause mortality ( OR , 0.47; 95% CI , 0.22–1.00), myocardial infarction ( OR , 0.78; 95% CI , 0.41–1.46), repeat revascularization ( OR , 1.13; 95% CI , 0.56–2.27), and stroke ( OR , 0.51; 95% CI , 0.20–1.33). Conclusions In this meta‐analysis, CTO percutaneous coronary intervention of the noninfarct‐related artery in patients presenting with ST‐segment–elevation myocardial infarction was associated with a significant reduction in major adverse cardiovascular events, cardiovascular mortality, and heart failure readmissions.
Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry
Fudim, Marat , Liu, Peter R., Shrader, Peter, Blanco, Rosalia , Kowey, Peter R. , Go, Alan S. , Thomas, Laine , Piccini, Jonathan P. , Allen, Larry A. , Fonarow, Gregg C. , Gersh, Bernard J. , Mahaffey, Kenneth W. , Hylek, Elaine M. , Peterson, Eric D.

Mayo Clinic

Journal of the American Heart Association | April 13, 2018 | Volume: 7 | Issue: 8 | Pages: No page available

10.1161/jaha.117.007987 | PMID 29654203 Get It

Background Mineralocorticoid receptor antagonist ( MRA ) therapy may be beneficial to patients with atrial fibrillation ( AF ), but little is known about their use in patients with AF and subsequent outcomes. Methods and Results In order to better understand MRA use and subsequent outcomes, we performed a retrospective cohort study of the contemporary ORBIT ‐ AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) registry. AF progression and cardiovascular outcomes were compared using propensity‐matched Cox proportional hazards modeling according to MRA use at baseline and new MRA use at follow‐up versus patients with no MRA use. Among 7012 patients with nonpermanent AF , 320 patients were taking MRA at enrollment, and 416 patients initiated MRA use during follow‐up. The mean patient age was 72.5 years, 56.3% were men, and 70.4% had paroxysmal AF . Among all patients taking MRAs, 434 (59.0%) had heart failure, 655 (89.0%) had hypertension, and 380 (51.6%) had both. After adjustment, new MRA use was not associated with reduced AF progression (hazard ratio, 1.18; 95% confidence interval, 0.88–1.58; P =0.27) but showed a trend towards lower risk of stroke, transient ischemic attack, or systemic embolism (hazard ratio, 0.17; 95% confidence interval, 0.02–1.23; P =0.08). Results were similar for a comparison of new MRA users and baseline MRA users compared with nonusers. Conclusions In community‐based outpatients with AF , the majority of MRA use was for heart failure and hypertension. MRA use also trended towards lower adjusted stroke risk. Future studies should test the hypothesis that MRA use may decrease the risk of stroke in patients with AF .
Fast and the Furious
Killu, Ammar M. , Kella, Danesh , Kapa, Suraj , Kella, Danesh K

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | April 13, 2018 | Volume: 11 | Issue: 4 | Pages: No page available

10.1161/circep.118.006391 | PMID 29654137 Get It

Recognizable phenotypes in CDG
Altassan, Ruqaia, Marques‐da‐Silva, Dorinda , Francisco, Rita , Jaeken, Jaak , Morava, Éva , Morava, Eva , Ferreira, Carlos R

Mayo Clinic

Journal of Inherited Metabolic Disease | April 13, 2018 | Volume: 41 | Issue: 3 | Pages: 541-553

10.1007/s10545-018-0156-5 | PMID 29654385 Get It

AbstractPattern recognition, using a group of characteristic, or discriminating features, is a powerful tool in metabolic diagnostic. A classic example of this approach is used in biochemical analysis of urine organic acid analysis, where the reporting depends more on the correlation of pertinent positive and negative findings, rather than on the absolute values of specific markers. Similar uses of pattern recognition in the field of biochemical genetics include the interpretation of data obtained by metabolomics, like glycomics, where a recognizable pattern or the presence of a specific glycan sub‐fraction can lead to the direct diagnosis of certain types of congenital disorders of glycosylation. Another indispensable tool is the use of clinical pattern recognition–or syndromology–relying on careful phenotyping. While genomics might uncover variants not essential in the final clinical expression of disease, and metabolomics could point to a mixture of primary but also secondary changes in biochemical pathways, phenomics describes the clinically relevant manifestations and the full expression of the disease. In the current review we apply phenomics to the field of congenital disorders of glycosylation, focusing on recognizable differentiating findings in glycosylation disorders, characteristic dysmorphic features and malformations in PMM2‐CDG, and overlapping patterns among the currently known glycosylation disorders based on their pathophysiological basis.
Predictors of Durability of Radiological Response in Patients With Small Bowel Crohn’s Disease
Deepak, Parakkal , Fidler, Jeff L. , Barlow, John M. , Sheedy, Shannon P. , Kolbe, Amy B. , Harmsen, William S. , Therneau, Terry M. , Becker, Brenda D., Loftus, Edward V. , Bruining, David H. , Loftus, Edward V , Deepak, Parakkal , Fletcher, Joel G. , Fidler, Jeff L. , Hansel, Stephanie L.

Mayo Clinic

Inflammatory Bowel Diseases | April 13, 2018 | Volume: 24 | Issue: 8 | Pages: 1815-1825

10.1093/ibd/izy074 | PMID 29668921 Get It

Left Ventricular Isovolumetric Relaxation Time Is Prolonged in Fetal Long-QT Syndrome
Clur, Sally-Ann B., Vink, Arja S. , Etheridge, Susan P. , Medina, Pascale G. Robles de, Rydberg, Annika , Ackerman, Michael J. , Wilde, Arthur A.M. , Benson, D. Woodrow , Herberg, Ulrike , Robles de Medina, Pascale G, Wilde, Arthur A, Donofrio, Mary T, Cuneo, Bettina F. , Clur, Sally‐Ann B. , Blom, Nico A. , Donofrio, Mary T.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | April 13, 2018 | Volume: 11 | Issue: 4 | Pages: No page available

10.1161/circep.117.005797 | PMID 29654130 Get It

Background: Long-QT syndrome (LQTS), an inherited cardiac repolarization disorder, is an important cause of fetal and neonatal mortality. Detecting LQTS prenatally is challenging. A fetal heart rate (FHR) less than third percentile for gestational age is specific for LQTS, but the sensitivity is only ≈50%. Left ventricular isovolumetric relaxation time (LVIRT) was evaluated as a potential diagnostic marker for fetal LQTS. Methods and Results: LV isovolumetric contraction time, LV ejection time, LVIRT, cycle length, and FHR were measured using pulsed Doppler waveforms in fetuses. Time intervals were expressed as percentages of cycle length, and the LV myocardial performance index was calculated. Single measurements were stratified by gestational age and compared between LQTS fetuses and controls. Receiver-operator curves were performed for FHR and normalized LVIRT (N-LVIRT). A linear mixed-effect model including multiple measurements was used to analyze trends in FHR, N-LVIRT, and LV myocardial performance index. There were 33 LQTS fetuses and 469 controls included. In LQTS fetuses, the LVIRT was prolonged in all gestational age groups ( P <0.001), as was the N-LVIRT. The best cutoff to diagnose LQTS was N-LVIRT ≥11.3 at ≤20 weeks (92% sensitivity, 70% specificity). Simultaneous analysis of N-LVIRT and FHR improved the sensitivity and specificity for LQTS (area under the curve=0.96; 95% confidence interval, 0.82–1.00 at 21–30 weeks). N-LVIRT, LV myocardial performance index, and FHR trends differed significantly between LQTS fetuses and controls through gestation. Conclusions: The LVIRT is prolonged in LQTS fetuses. Findings of a prolonged N-LVIRT and sinus bradycardia can improve the prenatal detection of fetal LQTS.